vs
Encompass Health Corp(EHC)とハッベル(HUBB)の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい($1.5B vs $1.5B、ハッベルの約1.0倍)。ハッベルの純利益率が高く(14.6% vs 9.5%、差は5.1%)。ハッベルの前年同期比売上増加率が高い(11.9% vs 9.9%)。ハッベルの直近四半期フリーキャッシュフローが多い($388.8M vs $116.7M)。過去8四半期でEncompass Health Corpの売上複合成長率が高い(8.3% vs 3.3%)
エンコンパスヘルスコーポレーション(旧Amcare、HealthSouth)は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
ハッベル・インコーポレーテッドは米国コネチカット州シェルトンに本社を置く企業で、1888年にハーヴェイ・ハッベルにより創業、1905年に同州で法人登録されました。住宅・非住宅建築、産業、公益事業分野向けの電気・電子製品の設計・製造・販売を主力事業としています。
EHC vs HUBB — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $1.5B | $1.5B |
| 純利益 | $146.1M | $217.7M |
| 粗利率 | — | 34.6% |
| 営業利益率 | 16.7% | 20.3% |
| 純利益率 | 9.5% | 14.6% |
| 売上前年比 | 9.9% | 11.9% |
| 純利益前年比 | 20.8% | 10.5% |
| EPS(希薄化後) | $1.43 | $4.06 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.5B | $1.5B | ||
| Q2 25 | $1.5B | $1.5B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.4B | $1.4B | ||
| Q2 24 | $1.3B | $1.5B | ||
| Q1 24 | $1.3B | $1.4B |
| Q4 25 | $146.1M | $217.7M | ||
| Q3 25 | $126.5M | $255.5M | ||
| Q2 25 | $142.1M | $244.2M | ||
| Q1 25 | $151.5M | $169.7M | ||
| Q4 24 | $120.9M | $197.0M | ||
| Q3 24 | $108.2M | $219.4M | ||
| Q2 24 | $114.1M | $213.6M | ||
| Q1 24 | $112.5M | $147.8M |
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 36.2% | ||
| Q2 25 | — | 37.2% | ||
| Q1 25 | — | 33.1% | ||
| Q4 24 | — | 33.8% | ||
| Q3 24 | — | 34.5% | ||
| Q2 24 | — | 35.0% | ||
| Q1 24 | — | 32.0% |
| Q4 25 | 16.7% | 20.3% | ||
| Q3 25 | 14.9% | 22.0% | ||
| Q2 25 | 16.2% | 22.7% | ||
| Q1 25 | 16.4% | 17.5% | ||
| Q4 24 | 14.3% | 19.3% | ||
| Q3 24 | 13.6% | 21.1% | ||
| Q2 24 | 14.3% | 20.7% | ||
| Q1 24 | 13.6% | 16.3% |
| Q4 25 | 9.5% | 14.6% | ||
| Q3 25 | 8.6% | 17.0% | ||
| Q2 25 | 9.7% | 16.5% | ||
| Q1 25 | 10.4% | 12.4% | ||
| Q4 24 | 8.6% | 14.8% | ||
| Q3 24 | 8.0% | 15.2% | ||
| Q2 24 | 8.8% | 14.7% | ||
| Q1 24 | 8.5% | 10.6% |
| Q4 25 | $1.43 | $4.06 | ||
| Q3 25 | $1.24 | $4.77 | ||
| Q2 25 | $1.39 | $4.56 | ||
| Q1 25 | $1.48 | $3.15 | ||
| Q4 24 | $1.18 | $3.65 | ||
| Q3 24 | $1.06 | $4.05 | ||
| Q2 24 | $1.12 | $3.94 | ||
| Q1 24 | $1.10 | $2.73 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $497.9M |
| 総負債低いほど良い | $2.4B | — |
| 株主資本純資産 | $2.4B | $3.8B |
| 総資産 | $7.1B | $8.2B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $497.9M | ||
| Q3 25 | $48.7M | $680.9M | ||
| Q2 25 | $99.1M | $399.6M | ||
| Q1 25 | $95.8M | $360.3M | ||
| Q4 24 | $85.4M | $345.0M | ||
| Q3 24 | $147.8M | $445.6M | ||
| Q2 24 | $154.4M | $406.5M | ||
| Q1 24 | $134.4M | $400.3M |
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | $1.4B | ||
| Q2 25 | $2.3B | $1.4B | ||
| Q1 25 | $2.3B | $1.4B | ||
| Q4 24 | $2.4B | $1.4B | ||
| Q3 24 | $2.3B | $1.7B | ||
| Q2 24 | $2.7B | $1.9B | ||
| Q1 24 | $2.7B | $1.9B |
| Q4 25 | $2.4B | $3.8B | ||
| Q3 25 | $2.4B | $3.7B | ||
| Q2 25 | $2.3B | $3.5B | ||
| Q1 25 | $2.2B | $3.3B | ||
| Q4 24 | $2.1B | $3.3B | ||
| Q3 24 | $2.0B | $3.2B | ||
| Q2 24 | $1.8B | $3.1B | ||
| Q1 24 | $1.7B | $2.9B |
| Q4 25 | $7.1B | $8.2B | ||
| Q3 25 | $6.9B | $7.5B | ||
| Q2 25 | $6.8B | $7.1B | ||
| Q1 25 | $6.6B | $6.9B | ||
| Q4 24 | $6.5B | $6.7B | ||
| Q3 24 | $6.5B | $6.9B | ||
| Q2 24 | $6.4B | $6.9B | ||
| Q1 24 | $6.2B | $6.9B |
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | 0.39× | ||
| Q2 25 | 1.02× | 0.41× | ||
| Q1 25 | 1.08× | 0.44× | ||
| Q4 24 | 1.14× | 0.44× | ||
| Q3 24 | 1.20× | 0.51× | ||
| Q2 24 | 1.46× | 0.63× | ||
| Q1 24 | 1.54× | 0.65× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $447.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $388.8M |
| FCFマージンFCF / 売上 | 7.6% | 26.0% |
| 設備投資強度設備投資 / 売上 | 14.8% | 3.9% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | 2.06× |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $874.7M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $447.5M | ||
| Q3 25 | $270.8M | $284.3M | ||
| Q2 25 | $270.2M | $260.6M | ||
| Q1 25 | $288.6M | $37.4M | ||
| Q4 24 | $278.8M | $432.4M | ||
| Q3 24 | $267.8M | $227.0M | ||
| Q2 24 | $217.4M | $239.6M | ||
| Q1 24 | $238.8M | $92.2M |
| Q4 25 | $116.7M | $388.8M | ||
| Q3 25 | $83.7M | $253.8M | ||
| Q2 25 | $113.3M | $220.7M | ||
| Q1 25 | $125.5M | $11.4M | ||
| Q4 24 | $80.1M | $364.4M | ||
| Q3 24 | $120.3M | $188.8M | ||
| Q2 24 | $60.5M | $205.7M | ||
| Q1 24 | $99.4M | $51.9M |
| Q4 25 | 7.6% | 26.0% | ||
| Q3 25 | 5.7% | 16.9% | ||
| Q2 25 | 7.8% | 14.9% | ||
| Q1 25 | 8.6% | 0.8% | ||
| Q4 24 | 5.7% | 27.3% | ||
| Q3 24 | 8.9% | 13.1% | ||
| Q2 24 | 4.6% | 14.2% | ||
| Q1 24 | 7.6% | 3.7% |
| Q4 25 | 14.8% | 3.9% | ||
| Q3 25 | 12.7% | 2.0% | ||
| Q2 25 | 10.8% | 2.7% | ||
| Q1 25 | 11.2% | 1.9% | ||
| Q4 24 | 14.1% | 5.1% | ||
| Q3 24 | 10.9% | 2.6% | ||
| Q2 24 | 12.1% | 2.3% | ||
| Q1 24 | 10.6% | 2.9% |
| Q4 25 | 2.37× | 2.06× | ||
| Q3 25 | 2.14× | 1.11× | ||
| Q2 25 | 1.90× | 1.07× | ||
| Q1 25 | 1.90× | 0.22× | ||
| Q4 24 | 2.31× | 2.19× | ||
| Q3 24 | 2.48× | 1.03× | ||
| Q2 24 | 1.91× | 1.12× | ||
| Q1 24 | 2.12× | 0.62× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
HUBB
| Grid Infrastructure | $717.0M | 48% |
| Industrial | $393.7M | 26% |
| Grid Automation | $218.9M | 15% |
| Electrical Products | $163.1M | 11% |